Angelo Raffaele Bianco

Author

Also Known As

A BIANCO, A Bianco, A R Bianco, A Raffaele Bianco, A. Bianco, A. R. Bianco, A. Raffaele Bianco, A.R. Bianco, AR Bianco, Angelo Bianco

130

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II Federico II University Hospital Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"University of Chieti-Pescara National Cancer Institute

About

Angelo Raffaele Bianco is an author at University of Naples Federico II specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	2.1K
2	Cell Biology	9	9	394
3	Health Sciences	2	2	62
4	Biostatistics	1	1	26
5	Cellular Physiology	1	1	26

Angelo Raffaele Bianco

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Fortunato Ciardiello, Roberto Bianco, V. Damiano, PubMed Tumor BiologyOncologyAngiogenesisAntitumor ActivityGastrointestinal Oncology	2000	380
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Fortunato Ciardiello, Roberto Bianco, Vincenzo Damiano, PubMed Tumor BiologyAntitumor ActivityMedicineTumor GrowthImmunology	1999	334
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Cataldo Bianco, Giampaolo Tortora, Roberto Bianco, PubMed	2002	246
Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Ivana Šestak, Jack Cuzick, Francisco Sapunar, The Lancet Oncology	2008	210
Familial papillary thyroid microcarcinoma: a new clinical entity Giovanni Lupoli, Giovanni Vitale, Michele Caraglia, The Lancet Tumoral PathologyMedicineSurgical PathologyThyroid DiseasePathology	1999	196
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer Rossella Lauria, Chiara Carlomagno, Michelino De Laurentiis, Cancer	1995	181
Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A Fortunato Ciardiello, V. Damiano, R. Bianco, JNCI Journal of the National Cancer Institute	1996	138
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. Sabino De Placido, Michelino De Laurentiis, Chiara Carlomagno, PubMed	2003	131
Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells A. Leardi, Michele Caraglia, Carmine Selleri, British Journal of Haematology	1998	121
Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial Sisto Perdonà, Riccardo Autorino, Sabino De Placido, The Lancet Oncology UrologyBreast OncologyBreast PainMedicineBrachytherapy	2005	116

Page 1